Rocket Pharmaceuticals
RCKT
RCKT
173 hedge funds and large institutions have $2.75B invested in Rocket Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 75 increasing their positions, 52 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
19% less capital invested
Capital invested by funds: $3.4B → $2.75B (-$649M)
55% less call options, than puts
Call options by funds: $4.13M | Put options by funds: $9.18M
Holders
173
Holding in Top 10
6
Calls
$4.13M
Puts
$9.18M
Top Buyers
| 1 | +$43.4M | |
| 2 | +$38.8M | |
| 3 | +$20.3M | |
| 4 |
Norges Bank
Oslo,
Norway
|
+$13.4M |
| 5 |
BlackRock
New York
|
+$12.8M |
Top Sellers
| 1 | -$59.7M | |
| 2 | -$28M | |
| 3 | -$23.5M | |
| 4 |
TCM
Tang Capital Management
San Diego,
California
|
-$19.2M |
| 5 |
VC
Vivo Capital
Palo Alto,
California
|
-$17M |